To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy
Clinical trial NCT01302899 · TERMINATED
Trial details
- NCT number
- NCT01302899
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-12-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.